Kenneth L. van Golen

Kenneth L. van Golen is an Associate Professor in the Department of Biological Sciences at the University of Delaware's College of Arts & Sciences. His research focuses on understanding the aggressive biology of Inflammatory Breast Cancer (IBC), particularly the role of RhoC GTPase in metastasis and tumor progression. He holds leadership roles in the IBC-International Consortium as Vice President. Dr. van Golen teaches advanced courses in cell biology and human physiology.

• Education: B.S. from Michigan State University, Ph.D. from University of Texas Health Science Center, Postdoctoral training at University of Michigan
• Research Interests: IBC mechanisms, therapeutic development for metastasis, tumor microenvironment interactions, and radiation-induced skin metastases
• Current Projects: PDGFRA signaling inhibition, Ambrosin-based RhoC inhibitors, TGF-beta pathway in metastasis, bacterial etiology studies

His lab remains one of ~24 globally dedicated to IBC research, emphasizing translational therapies and molecular mechanisms.